CRF Health appoints Tom Haag as vice president, quality assurance

Formerly the global head of digital development and transformation QA with Novartis, Haag led on end-to-end quality and data integrity oversight for all Novartis digital development and new technology initiatives. This included transition to an e-technology-ready quality management system for the Novartis clinical trial process.  Haag’s fifteen-year career with the major global player demonstrates his expertise in the areas of eClinical systems, data visualization and data stewardship. Over the last 6 years, he has been solely focused on the adoption of eSource, e-informed consent, mobile patient data and novel trial settings.

In his new role, Haag will lead CRF Health’s QA organization to support the company’s efforts to change the quality of patients’ lives by ensuring that safe and effective medicines are available in a timely manner.  Speaking on his appointment, Haag says: “My professional mission is to solve problems inherent in the execution of clinical trials in evolving technical and regulatory landscape.  Clinical development needs to evolve in such a way that research trials are modernized to promote data integrity, increase efficiency, and reduce patient and researcher burden. In this way medicines and therapies can be introduced to the market with a higher degree of confidence and quality.”

Discussing the appointment, CRF Health’s chief executive officer, Rachael Wyllie, said: “Quality underpins everything we do at CRF Health and Tom’s experience and leading industry insight in Clinical Quality Assurance will be a great asset to us, not only in the delivery of current services and products but also as we design new, market-leading solutions.”

Crf health appoints tom haag, vice president, quality assurance